Perivascular delivery of heparin for the reduction of smooth muscle cell proliferation after endothelial injury
- 1 June 1999
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 60 (1) , 129-142
- https://doi.org/10.1016/s0168-3659(99)00071-1
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Pharmacological Approaches to the Prevention of Restenosis Following AngioplastyDrugs, 1993
- Experimental models of coronary artery restenosisJournal of the American College of Cardiology, 1992
- Clinical trials of restenosis after coronary angioplasty.Circulation, 1991
- The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplastyJournal of the American College of Cardiology, 1991
- IntroductionJournal of the American College of Cardiology, 1991
- Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia.Circulation, 1989
- Restenosis After Successful Percutaneous Transluminal Coronary Angioplasty: Serial Angiographic Follow-Up of 229 PatientsJournal of the American College of Cardiology, 1988
- Restenosis after percutaneous transluminal coronary angioplasty (PTCA): A report from the PTCA registry of the national heart, lung, and blood instituteThe American Journal of Cardiology, 1984
- A world survey of anticoagulation practice in clinical microvascular surgeryBritish Journal of Plastic Surgery, 1982
- Inhibition of rat arterial smooth muscle cell proliferation by heparin. In vivo studies with anticoagulant and nonanticoagulant heparin.Circulation Research, 1980